Introduction
Mitochondria are dynamic organelles performing various cellular functions, such as energy production, fatty acid and amino acid oxidation, iron metabolism and apoptosis. 1 Mitochondrial cardiomyopathy, a common manifestation of mitochondrial respiratory disorders, involves development of cardiac hypertrophy and heart failure. 2, 3 In heart failure, mitochondrial structural damage and dysfunction, including an increase in mitochondrial oxidative damage, impairment of mitochondrial respiration and abnormal mitochondrial substrate use, occur. [4] [5] [6] The protein p32/C1qbp (complement component 1q binding protein), conserved among eukaryotic organisms, is primarily localized in the mitochondrial matrix and is associated with several matrix proteins. 7, 8 We previously showed that p32-deficient mice exhibited embryonic lethality.
Notably, p32 formed protein complexes with a variety of molecules and was proposed to act as a multifunctional chaperone protein. [9] [10] [11] [12] Additionally, p32 regulated metabolism to maintain oxidative phosphorylation (OXPHOS) in cancer cells and was highly expressed in prostate cancer. 13, 14 A p32 mutation was the suspected cause of mitochondrial respiratory chain disorder in one patient. 15 In response to accumulation of unfolded or misfolded proteins at levels exceeding the chaperone capacity of the organelle, cells mount a mitochondrial unfolded protein response (UPR mt ). The UPR mt is a mitochondria-to-nucleus signal transduction pathway resulting in induction of mitochondrial protective genes, including mitochondrial molecular chaperones and proteases, to re-establish protein homeostasis within the mitochondrial protein-folding environment. 16 The integrated stress response (ISR) is an evolutionarily conserved homeostatic program activated by specific pathological states. These include iron deficiency, amino acid deprivation, viral infection and misfolding of proteins within the endoplasmic reticulum (ER). The latter is also known as ER stress. Although apparently disparate, each of these stresses increases phosphorylation of a translation initiation factor, eIF2a, to induce activating transcription factor 4 (ATF4) translation and expression of protective genes. 17 Recently, functional interactions between two organelles, mitochondria and the ER, have attracted attention. 18, 19 Evidence has shown existence of a signalling pathway transmitting ER dysfunction to the mitochondria. Interestingly, in human patients with mitochondrial myopathy caused by OXPHOS deficiencies, the cytokine fibroblast growth factor 21 (FGF21) was secreted from muscle tissue, suggesting that OXPHOS dysfunction may mimic fasting and induce release of the fasting hormone FGF21. 20 These observations suggested that UPR mt , the ISR and expression of FGF21 act as protective responses against various mitochondrial-related diseases.
Cardiac muscle, with the highest mitochondrial abundance of all tissues, is an excellent system for studying the physiological role of a mitochondrial protein. To examine the potential role of p32 in cardiac function in vivo, we generated and analysed cardiomyocyte-specific conditional p32 knockout (cKO) mice using the Cre-loxP approach. Mice homozygous for the exon 3 floxed p32 allele (p32 flox/flox ) were crossed with a-myosin heavy chain (aMHC)-MerCreMer transgenic mice, which harbor cardiomyocytespecific Cre activity in a tamoxifen-dependent manner. We also crossed them with Myh6-cre transgenic mice. Using mice generated with these two approaches, we demonstrated the role of p32 as a regulator of homeostasis in cardiomyocytes. Deletion of p32 led to cardiomyopathy, a result of mitochondrial dysfunction at 2 months old, and these mice died beginning at the age of 12 months. We found significantly increased expression of mitokines and of genes associated with the integrated ER response in the p32cKO hearts. These data suggested that mitochondrial dysfunction caused by p32 deficiency affects cellular homeostasis and induces a protective response against cardiomyopathy.
Methods
Care of all animals was in compliance with the Kyushu University animal care guidelines (#A26-044). All experimental procedures conformed to the Guide for the Care and Use of Laboratory Animals, Eighth Edition, updated by the US National Research Council Committee in 2011. The animals were treated in accordance with the guidelines stipulated by the Kyushu University Animal Care and Use Committee.
Animals
Mice homozygous for the exon 3 floxed p32 allele (p32 flox/flox ) were generated as described previously. 9 We obtained hemizygous mice expressing a tamoxifen-inducible Cre recombinase protein fused to two mutant oestrogen receptor ligand-binding domains (MerCreMer), under the aMHC promoter (aMHC-MerCreMer) (Tg(Myh6-cre/Esr1), and expressing a Cre recombinase under the aMHC promoter (aMHC-Cre) (cardiac-specific alpha myosin-heavy chain [Myh6] promoter) from Jackson Laboratories. We then generated the two types of double-transgenic mice by mating p32 flox/flox mice with either aMHC-MerCreMer mice or aMHC-Cre mice.
One type was p32 flox/flox /aMHC-MerCreMer mice with tamoxifen-inducible p32 deletion in the adult myocardium. The other type was p32 flox/flox / aMHC-Cre mice with p32 ablation in the neonatal cardiac muscle.
Cardiomyocyte-specific excision of the p32 gene in adult mice
Mice at 15-20 weeks of age were treated with tamoxifen (30 mg/kg/day) by daily intraperitoneal injections for five successive days. Tamoxifen was diluted in ethanol/oil (10/90% v/v). The p32 flox/flox mice were used as a control for p32 flox/flox /aMHC-MerCreMer mice.
Transthoracic echocardiography
Echocardiographic measurements were performed on mice, anesthetized with 1-2% isoflurane gas, using the Vevo 770 High Resolution In Vivo Imaging System (Visualsonics, Toronto, Canada). Heart rate was monitored throughout each session using an electrocardiogram transducer pad. Left ventricular internal dimension at the end of diastole and at the end of systole, as well as diastolic left ventricular wall dimension, were measured digitally on M-mode tracing.
Histology and immunofluorescence
The hearts were each excised and fixed in 10% formalin. From the three transverse sections of the apex, middle ring, and base, 5 lm sections were cut and stained with Masson's trichrome stain. Sections were analysed using a colour-based threshold tool in ImageJ software (National Institutes of Health, Bethesda, MD). The collagen volume fraction, calculated as the sum of connective tissue area divided by the total area, was determined by measuring six to eight fields per heart.
Oxygen consumption assay
Oxygen consumption rate (OCR) was measured as previously described. 21 An aliquot of crude mitochondria from each mouse heart was placed in the reaction chamber of a Flux Analyzer (Seahorse Bioscience-Agilent, North Billerica, MA) and oxygen concentrations were measured in 1 mL reaction volumes at 37 C with substrates (NADH and glutamate with ADP, succinate and glycerol-3-phosphate; Sigma-Aldrich, St. Louis, MO) and inhibitors according to a standard protocol. 21 Oxygen consumption rate (II-III-IV) was represented as the mean ± SEM, in nmol O 2 consumed per minute per cell.
Real-time PCR analysis
Total RNA was extracted using the RNeasy kit (Qiagen, Hilden, Germany) and cDNA was synthesized using total RNA, random 6 mers, Table S1 in Supplementary material online. The expression level of each mRNA was normalized to the level of 18S ribosomal RNA, obtained from the corresponding reverse transcription product.
Western blotting
Briefly, heart tissues were immediately frozen in liquid nitrogen. The tissues were lysed with lysis buffer, homogenized by sonication, and then subjected to immunoblotting as described previously. 9 (see Material and
Methods in Supplementary material online for details.)
Immunofluorescence, immunohistochemistry, and electron microscopy
Mice at different stages of disease were anesthetized with an overdose of sevoflurane. After exsanguination under deep anesthesia, tissue sections were prepared from the hearts and fixed in 4% paraformaldehyde to obtain paraffin-embedded coronal sections for hematoxylin and eosin staining (H&E), Masson's Trichrome staining (MT) and for immunohistochemistry. 9, 14 For electron microscopy, 50-100 nm ultrathin sections were prepared, stained with uranyl acetate and lead citrate and photographed with a JEOL (Akishima, Tokyo, Japan) 1200 electron microscope (see Material and Methods in Supplementary material online for details).
Ornithine transcarbamylase (OTC) activity
OTC activity in the mouse heart was measured as described by Lee and Nussbaum 22 with modifications. Briefly, 2-10 lg total cellular protein was added to 700 lL reaction mixture (5 mM ornithine, 15 mM carbamoyl phosphate and 270 mM triethanolamine, pH 7.7), and samples incubated at 37 C for 30 min. Reactions were stopped by adding 250 lL of 3:1 phosphoric acid:sulfuric acid (by volume). Citrulline production was then determined by adding 50 lL of 3% 2,3-butanedione monoxime, incubating at 95-100 C in the dark for 15 min and measuring absorbance at 490 nm.
LC-MS and data analysis
Heart-derived metabolites were analysed by LC-MS based on reverse phase ion-pair chromatography and hydrophilic interaction chromatography modes coupled with a triple quadrupole mass spectrometer: LCMS-8040 (Shimadzu, Kyoto, Japan) (see Material and Methods in Supplementary material online for details).
Data analysis
The data are expressed as means ± SEM of the indicated number of experiment and mice. The unpaired Student's t-test was used to determine statistical differences between two groups. Values of *P < 0.05, **P < 0.01 or ***P < 0.005 were considered to be statistically significant. The modified Wilcoxon statistic was used for survival time ***P < 0.0001.
Results
3.1 Knockdown of p32 provoked cardiac dysfunction in the adult myocardium
As described previously, systemic KO of p32 resulted in embryonic lethality. 9 To clarify the physiological role of p32 in the adult myocardium, we constructed mice with two types of genetic p32 ablation in the heart. One type was a temporally controlled KO of p32 in the adult heart and the other was a genetic ablation of p32 during postnatal periods. First, we crossed the mice bearing a p32 flox allele with aMHCMerCreMer mice and generated tamoxifen-inducible cardiac-specific p32-knockout mice (p32 iCKO ). Intraperitoneal injection of tamoxifen (30 mg/kg) for five sequential days successfully downregulated p32 protein levels in the hearts of p32 iCKO compared with those in control mice (p32 WT ) (n = 7) ( Figure 1A) . We assessed cardiac function 6 and 12 weeks after termination of tamoxifen treatment (n = 10). Compared with p32 WT , p32 iCKO mice exhibited dilatation of the left ventricle and impaired contractile function ( Figure 1B and Table 1 ). There was no acute aggravation of this phenotype from 6 to 12 weeks ( Table 1 ). The mRNA levels of stress-responsive genes, such as ANF and bMHC, were significantly higher in the myocardium of p32 iCKO compared with that of p32 WT mice (n = 8) ( Figure 1C ). The ratio of heart weight/body weight was also elevated in p32 iCKO compared with p32 WT mice (n = 10) ( Figure   1D ). p32 iCKO mice had significantly more cardiac fibrosis (see Supplementary material online, Figure S1A ). These results indicated that ablation of cardiac p32 only in adulthood was sufficient to provoke cardiac dysfunction in the adult heart.
Deletion of p32 during the postnatal period also caused cardiac dysfunction
We then examined effects of genetic ablation of p32 during the postnatal period. We crossed mice bearing the p32 flox allele with aMHC-Cre mice and generated cardiac-specific p32-deficient mice (p32 f/f ;myh-cre). Rather unexpectedly, the cardiac-specific p32-deficient mice were born normally. Similar to the results obtained in p32 iCKO , p32 f/f ;myh-cre exhibited cardiac dysfunction, compared with control mice (p32 f/f ), at an age as young as 2 months (n = 8) ( Figure 2A and Table 2 ). This functional deterioration was accompanied by increased levels of mRNA for ANF and bMHC in mice at 2 months of age and, as they aged further, expression levels gradually increased (n = 48) ( Figure 2B ). The ratio of heart weight/body weight was also elevated in p32 f/f ;myh-cre compared with p32 WT mice at 5 months of age (n = 5) ( Figure 2C ). The p32
;myh-cre mice had significantly more cardiac fibrosis at 2 months and cardiac fibrosis became progressively more severe as they aged (n = 8) ( Figure 2D ). The mice also had higher mRNA expression of fibrosis-related genes than did their respective controls (see Supplementary material online, Figure S1B ). We next evaluated the survival rate of the p32 f/f ;myh-cre mice (n = 25 for each group). These mice died beginning at 12 months of age and their median lifespan was 14 months. During this 14-month period, no p32 f/f mice died ( Figure 2E ). Thus, based on our findings using two types of gene ablation, we concluded that p32 is required for the maintenance of normal cardiac function after birth.
Involvement of p32 in translation and oxygen consumption rate in the heart
We previously observed that levels of complexes I, III and IV were strongly decreased in p32 KO MEF cells. 9 We did not observe lower mitochondrial DNA copy numbers or decreased RNA expression in ;myh-cre mice, compared with in controls (see Supplementary material online, Figure S2 ). Protein levels of COX1 and COXIII, encoded by mitochondrial DNA, were significantly lower in hearts from p32 f/f ;myh-cre than from p32 f/f mice, at 2 months of age (n = 6) ( Figure 3A ). There were also decreased levels of COXI and COXIII proteins in hearts from p32-deficient mice at 6 months of age (see Supplementary material online, Figure S3 ). To evaluate the functional effects of this mitochondrial impairment, we measured the OCR in mitochondria from hearts of 6-month-old p32 f/f ;myh-cre mice. The OCR of complexes II-III-IV in cardiac mitochondria from p32 f/f ;myh-cre mice (n = 6) was significantly lower than in those from p32 f/f mice ( Figure 3B ).
Next, to investigate the defect in mitochondrial protein synthesis, mitochondria from wild-type and knockout hearts were pulse-labelled with a mixture of [
35 S]-methionine and -cysteine. The mitochondrial protein synthesis was strikingly reduced in p32-deficient heart mitochondria (n = 3) ( Figure 3C ). These results suggested that p32 also contributed to mitochondrial translation in the mice at an early stage and, therefore, to oxygen consumption by cardiac mitochondria. Total ATP and ADP levels were not different in wildtype and p32KO hearts (see Supplementary material online, Figure S4 ).
Although p32 protein was assumed to reside primarily in the mitochondrial matrix, it was reported that this protein was also localized at the cell surface, in the nucleus and cytosol, and within secretory granules. 23, 24 In addition, Tom22 co-immunoprecipitated with p32, TFAM, Tom20 and COXI ( Figure 3D ). By immunohistochemistry, p32 was colocalized with the mitochondrial matric protein COXI (see Supplementary material online, Figure S5 ). This observation suggested that p32 was localized primarily in mitochondria in the myocardium, consistent with a previous report using electron microscopy and an immune-gold labelling antibody against p32. 25 Previously, we showed that endogenous p32 interacted with mitochondrial mRNA and mitoribosome species in MEF cells. 9 We therefore investigated the possibility that p32 can interact with mitochondrial mRNA and ribosomal protein interaction in the mouse heart. We observed a substantial enrichment of mitochondrial mRNA and mitochondrial ribosomal protein MRPS22 after immunoprecipitation with a p32 antibody ( Figure 3E and F) . Taken together, these data indicated that p32 can associate with mitochondrial mRNAs and ribosomal protein in mouse heart tissue. This suggested that p32 can act as an RNA and protein chaperone and that, therefore, p32 deficiency might affect mitochondrial translation and OCR in the mouse heart.
Deletion of p32 caused abnormal mitochondrial structure
We also performed ultrastructural analysis by electron microscopy. Hearts from p32 f/f mice showed alignment of mitochondria with densely packed cristae, characteristic of normal cardiac muscle ( Figure 4A ).
Hearts from p32
f/f ;myh-cre mice showed less ordered mitochondrial alignment, aggregation and mitochondrial size variations, with a loss of matrix density and apparent destruction of intra-mitochondrial structure ( Figure 4A ). These alterations in mitochondrial morphology were consistent with changes in mitochondrial bioenergetics, indicating decreased mitochondrial homeostasis in the p32-deficient hearts. We also observed enlarged mitochondria with further abnormalities in their internal structures, such as loss of cristae and formation of inner membrane vesicles, in the p32-deficient hearts ( Figure 4B and C) . Interestingly, we observed a disordered structure, elongated mitochondria and vacuolation in the mitochondria with partial collapse ( Figure 4B ). These observations indicated therefore, that p32 is required to maintain normal mitochondrial structure.
To further investigate the link between mitochondrial morphology and modification of fission or fusion proteins, we measured fission protein, Dynamin-1-like protein (Drp1) and fusion protein, Optic atrophy protein 1 (OPA1) expression in the p32 deficient hearts (n = 6). We observed decreased levels of long-Opa1 (l-OPA1) and increased levels of ration of short-OPA1 (s-OPA1)/OPA1 in the p32 deficient hearts ( Figure 4D ). Because long OPA1 controls cristae remodelling independently from mitochondrial fusion, we attributed the accumulated loss of cristae and disordered cristae structure to increased s-OPA1 in the p32 deficient mitochondria.
By western blotting analysis of 4-hydroxy-2-nonenal (4-HNE) modified proteins, we detected increased oxidative stress in p32-deficient mouse hearts, based on elevated 4-HNE staining compared with that in controls (n = 6) ( Figure 4E and Figure S6 in Supplementary material online). The accumulation of abnormal mitochondria might have resulted in increased oxidative stress, further leading to cardiomyocyte dysfunction.
Reduced mammalian target of rapamycin (mTOR) signalling in p32-deficient hearts
We examined phosphorylation of mTOR and AMP-activated protein kinase (AMPK) signalling proteins in hearts from p32 f/f ;myh-cre mice to determine whether mitochondrial dysfunction affected metabolic signal transduction pathways in the p32-deficient cardiomyocytes. In heart extracts from p32 f/f ;myh-cre mice, we observed increased phosphorylation of AMPKa and 4E-BP1, and decreased phosphorylation of S6K (n = 6) ( Figure 5A and B) . This suggested that the mTOR pathway was inhibited in p32-deficient hearts. Levels of 4E-BP1, which binds to eIF4E and inhibits translation, were also increased in hearts from the p32 f/ f ;myh-cre mice ( Figure 5A and B) . This suggested that cytosolic translation was inhibited in the hearts of p32 f/f ;myh-cre mice ( Figure 5C ).
UPR mit and ISR were induced in p32-deficient hearts
Recent studies demonstrated interactions between UPR mt and UPR ER in C. elegans and in mammals. 26, 27 Phosphorylation of eIF2a at Ser 51, a well-established indicator of ER stress, was elevated in the hearts of p32
f/f ;myh-cre compared with control mice (n = 7) ( Figure 6A (E) In control heart lysates, p32 was immunoprecipitated using an anti-p32 antibody or control IgG. Then the RNA was extracted from the immunoprecipitated samples and each RNA species measured by qPCR at 2 times. Relative mRNA expression levels are shown for several mitochondria-encoded genes. (F) Mitochondrial lysates from heart samples were immunoprecipitated with an anti-p32 antibody or control IgG and analysed by western blotting with antibodies for the indicated proteins (p32 and Mrps22) at 2 times. Samples marked 'flow through' and 'elution' represent non-immunoprecipitated and immunoprecipitated fractions, respectively. Representative blot is shown. UPR-related molecule, IRE1a, a sensor RNase located in the ER membrane, was also upregulated in p32-deficient hearts ( Figure 6A) . Inhibition of mitochondrial function causes UPR mt . 28 As expected, mRNA expression of Hsp70, Hsp75 and Hsp10, markers of UPR mt , was significantly higher in hearts from p32 f/f ;myh-cre than in those from p32 f/f mice (n = 6). This indicated that UPR mt was stimulated in the p32-deficient hearts ( Figure 6B ). To investigate potential disease-causing processes, we performed ISR gene expression profiling. Real-time PCR analysis showed upregulation of a number of genes activated by the integrated stress response (ISR: e.g. Atf4, Ddit3/Chop, Mthfd2, Slc7a5, Angptl6, and Trib3) in hearts from p32 f/f ;myh-cre, compared with control mice as well as with disrupted mitochondrial homeostasis (n = 6) ( Figure 6B and Table 3 ). Trib3, Gdf15 and Fgf21 gene expression were evident in hearts of 2-month-old mice because of dysfunctional mitochondrial translation. However, expression of these genes did not increase further until 9 months of age (n = 34 each group) ( Figure 6C) . Therefore, maladaptive activation of the ISR, downstream of eIF2a phosphorylation, was elicited by mitochondrial dysfunction in the p32cKO hearts. These results indicated that the ISR response was activated in p32-deficient hearts through the ER stress response.
Mitokine and oxidative stressassociated gene expression
We measured levels of mRNA for heme oxygenase-1 (Hmox1) and thioredoxin reductase 1 (Txnrd1), both oxidative stress markers, 29 using real-time PCR ( Table 3) . Levels of Hmox1 and Txnrd1 mRNA in hearts from p32
f/f ;myh-cre mice were higher than in those from control mice, both at 20 weeks of age. Thus, an oxidative stress response was induced in the p32-deficient hearts.
In hearts from p32 f/f ;myh-cre mice, compared with controls, there were marked increases in mRNA for GDF15 and FGF21, novel diagnostic markers for mitochondrial disease 30, 31 ( Figure 6C and Table 3 ). FGF21 is a mitokine that can potentially affect whole-body energy metabolism and longevity and GDF15 is a novel anti-hypertrophic regulatory factor in the heart. 32 Therefore, these mitokines are potentially protective against progression of cardiomyopathy. p32/C1qbp deficiency causes cardiomyopathy
Decreased ornithine transcarbamylase (OTC) activity
We examined the metabolic changes that were induced by mitochondrial dysfunction and were associated with the abnormal pathologies in the hearts from p32 f/f ;myh-cre mice. To do this, we performed a comprehensive metabolomic analysis of hearts from 20-week-old myh-cre and p32
f/f mice (n = 810 each group). The metabolomic analysis of the p32-deficient mouse hearts showed increased ornithine and decreased citrulline metabolites, suggesting that the urea cycle was affected ( Figure  7A ). The urea cycle consists of five reactions, two mitochondrial and three cytosolic. We measured activity and expression of carbamoyl phosphate synthetase 1 (CPS1) and OTC, which are both localized in the mitochondrial matrix. In hearts from p32 f/f ;myh-cre mice, OTC, but not CPSI, activity was significantly lower than in controls (n = 4) ( Figure  7B) . However, compared with controls, levels of OTC mRNA and protein were not decreased in the hearts from p32 f/f ;myh-cre mice ( Figure  7C and D) (n = 4) . Expression of other urea cycle enzymes such as Arg1 and Asl1 was increased ( Figure 7C) , suggesting that p32 might affect the urea cycle in heart mitochondria ( Figure 7E ). In conclusion, p32 cKO mice, generated by two different types of Cre recombinase transgenic approaches, myh6-cre and Myh6-cre/Esr1, developed cardiomyopathy because of impaired mitochondrial function.
Discussion
Our study showed that loss of p32 in cardiomyocytes led to a heart failure that was multifactorial in nature. We found increased ER and mitochondrial dysfunction, but this did not lead to apoptosis. The major new findings of this study were: (i) Mitochondrial p32 in heart was involved in mitochondrial translation and OXPHOS function after birth; (ii) Deficiency of p32 in the heart resulted in cardiac dysfunction at 2 months of age, with progressive worsening and death beginning at 12 months; (iii) A protective response with an ISR occurred in the p32-deficient hearts; (iv) Deficiency of p32 in the heart affected the mTOR signal transduction pathways; and (v) Metabolomic analysis showed decreases in some mitochondrial metabolites, such as those involved in the urea cycle, in p32-deficient hearts. Furthermore, we observed a dramatic loss of cristae and vacuolation in mitochondria from p32-deficient cardiomyocytes. Our results strongly suggested that these various mitochondrial alterations in p32-deficient cardiomyocytes resulted from impaired mitochondrial function (see Supplementary material online, Figure S7 ).
p32 as a mitochondrial RNA and protein chaperone
The heart, similar to the brain, has a high demand for ATP and is dependent on high-energy phosphate production in the mitochondria. However, only few studies addressed whether abnormalities in mitochondrial translation played a role in heart failure. Our previous results suggested that p32 is an RNA and protein chaperone required for functional mitoribosome formation within mitochondria. We also observed, by LC-MS/MS, binding of p32 to many proteins related to nucleoids, to RNA binding and translation machinery and to many enzymes. 9 In our present study, p32 deficiency in the heart led to decreased levels of COX1 and COXIII protein, which is encoded by mitochondrial DNA at 2 months, and to a lower OCR ( Figure 3A and B) . These results suggested that p32 is involved in mitochondrial translation and OXPHOS function and acts as an RNA and protein chaperone in the heart. In this study, we compared the p32 f/f mice with Myh6-Mer-Cre-Mer; p32 f/f mice because we did not observe effects of tamoxifen treatment (see Supplementary material online, Figure S8A ). We also checked the effects of Cre overexpression on p32 þ/þ and p32 f/f mice, based on gene expression. However, we observed no differences in expression of marker genes such as ANP, bMYH and FGF21 in p32 þ/þ : myh-cre mice,
suggesting that Cre overexpression did not affect the gene expressions 
Abnormal mitochondrial structure in the p32-deficient heart
By electron microscopy, the p32-deficient hearts showed mitochondria with less ordered alignment, more aggregation and size variations, a loss of matrix density in which intra-mitochondrial structure appeared to be destroyed ( Figure 4 ). This suggested that p32, through its interactions with several proteins, was involved in other mitochondrial functions in addition to OXPHOS. Damaged mitochondria are engulfed by autophagosomes for lysosomal degradation by the quality control mechanism that engages the autophagy machinery. 33 In the hearts of p32 cKO mice, it is possible that damaged mitochondria were not eliminated by autophagy. Mitochondrial fusion is a complex process involving fusion of four lipid bilayers. Damaged mitochondria are usually fragmented by fission proteins and these fragmented mitochondria are then prevented from refusing with one another. 34 Optic Atrophy 1 (OPA1) is a fusionpromoting dynamin-related protein of the inner mitochondrial membrane, and is mutated in dominant optic atrophy. OPA1 is protective against apoptosis by preventing cytochrome c release, independently of its effects on mitochondrial fusion. 35 Tightness of the cristae junctions was correlated with oligomerization of two forms of OPA1, a soluble form in the intermembrane space and another integral to the inner membrane. 35 OPA1 cleavage by Metalloendopeptidase OMA1 causes accumulation of short OPA1 variants when mitochondrial DNA is depleted or mitochondrial activities impaired. 36 Our results suggested that p32-deficient hearts, which had decreased mitochondrial OXPHOS activity, also have increased levels of short OPA1 variants, potentially leading to abnormal mitochondrial morphology. Mitochondrial quality control is a potentially important mechanism for maintaining cellular energy homeostasis. Therefore, our results offered a possible explanation for previous reports of p32-mediated regulation of mitochondrial bioenergetics. Additionally, in our study, electron microscopy revealed a dramatic change in mitochondrial morphology in the heart tissue of p32 cKO mouse, resulting from the reduced OXPHOS function.
Protective responses (ER stress response and mitokines) against cardiomyopathy
In our study, decreased heart function in vivo was observed in p32 iCKO and p32 cKO mice based on both echocardiography and gene expression of heart failure markers. However, these mice did not die until the age of 1 year. The UPR mt may be considered a hormetic mechanism that extends lifespan of an organism despite mitochondrial dysfunction. ATF4 is a master regulator of the ISR. In ISR, a variety of stresses, including amino acid starvation, glucose starvation, ER stress, hypoxia and oxidative stress, can promote phosphorylation of eIF2a, followed by upregulation of ATF4 to activate expression of stress-responsive genes. 37, 38 Gdf15 is a novel diagnostic marker for mitochondrial diseases and its expression is upregulated by ATF4 in MEF cells. 39 FGF21 is generally considered to be a hepatic hormone involved in control of glucose, lipid and energy metabolism. FGF21 released by cardiomyocytes acts as an antioxidant factor in the heart, preventing accumulation of reactive oxygen species caused by inflammatory or hypertrophic conditions. 40 Taken together, our findings suggest that the ISR pathway may also contribute to induction of Fgf21 and Gdf15 expression in response to defective energy metabolism. Additionally, the ISR pathway may play a role in protecting the heart, in association with alterations in the hypertrophic response.
In our study, we demonstrated that loss of p32 in cardiomyocytes led to a heart failure that was multifactorial in nature. This heart failure induced an ISR through ER stress. Overall, our findings are the first to indicate a vital role for p32 in cardiac mitochondrial homeostasis.
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